Background: The potential benefit of silymarin (special extract from the fruits of Silybum
marianum) in the treatment of liver diseases remains a controversial issue. Methods: For this …

Background and Aims: Hepatitis B virus (HBV) infection is a worldwide problem. It is
estimated that 400 million people are suffering from this infection. We conducted a …

Hepatitis C infection has come to the top of virus-induced liver diseases in many parts of the
world. In Iran, it seems that its prevalence in general population is less than 1%, which is …

In Iran, the prevalence of hepatitis C virus (HCV) infection is relatively low according to the
population-based epidemiological studies. However, the epidemiology of HCV is changing …

An association between diabetes mellitus (DM) and liver cirrhosis is well‐known, but
estimates of the prevalence of DM in patients with liver cirrhosis vary widely. A systematic …

Hepatitis C virus (HCV) infection is a significant cause of morbidity and mortality in
hemodialysis (HD) patients. The reported prevalence of HCV among the HD population has …

Abstract Hepatitis B (HBV) and C (HCV) viruses are the most important infections transmitted
by the parenteral route in patients receiving maintenance dialysis. The prevalence varies …

Abstract Background The highest Hepatitis C Virus (HCV) prevalence in the world occurs in
Egypt. Several studies from different parts of the world have found that 13% to 33% of …

Background: The prevalence of hepatitis viruses in hemodialysis patients has been reported
to be much greater than in the general population. Attention to local data, effectively guides …

Background. Chronic kidney disease (CKD) and end-stage renal disease (ESRD) are
emerging as globally important public health problems, and will necessitate improvements …